Coegin Pharma AB (NGM: COEGIN)
Health Care · Biotechnology · SE
Skr2.94
-2.33% today · -31.6% 1Y
Coegin Pharma AB (NGM: COEGIN) operates in the Biotechnology industry within the Health Care sector. The company is valued at $8.88M.
Over the last twelve months the share price has lost 31.6%, trading between 2.94 and 9.52.
Tweenvest scores Coegin Pharma AB across four factors: quality 25/100, value 63/100. Its strongest factor is value.
COEGIN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $8.88M
- Revenue (TTM)
- $65.42K
- P/E
- —
- EPS
- -0.84
- Dividend yield
- —
- Beta (5Y)
- 1.01
- 52-week high
- Skr9.52
- 52-week low
- Skr2.94
- Avg volume (3M)
- —
- Shares outstanding
- 28.59M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $265.43 | +0.18% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $440.98 | +0.38% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.44 | +0.22% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.78 | +0.13% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $825.89 | -0.98% |
| argenx SEENXTBR: ARGX | $65.85B | €864.20 | -4.19% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $139.44 | -3.88% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.